Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Annals of the Rheumatic Diseases|December 23, 2020
2020 EULAR points to consider for the prevention, screening, assessment and management of non-adherence to treatment in people with rheumatic and musculoskeletal diseases for use in clinical practiceValentin Ritschl, Tanja A Stamm, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|May 8, 2021
2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritisElena Nikiphorou, Eduardo José Ferreira Santos, Andrea Marques, et al.
RMD Open|November 8, 2020
Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to considerValentin Ritschl, Tanja A Stamm, Daniel Aletaha, et al.
Annals of the Rheumatic Diseases|June 14, 2024
EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 updateMaarten de Wit, Krystel Aouad, Muriel Elhai, et al.
Age and Ageing|September 6, 2003
Cross-national comparisons of the Cambridge Cognitive Examination-revised: the CAMCOG-R: results from the European Harmonization Project for Instruments in DementiaFrans R J Verhey, Felicia A Huppert, Edith C C M Korten, et al.
Annals of the Rheumatic Diseases|November 3, 2022
2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseasesGeorge E Fragoulis, Elena Nikiphorou, Mrinalini Dey, et al.
Seminars in Arthritis and Rheumatism|December 20, 2023
Patient outcomes in longitudinal observational studies (POLOS) of rheumatoid arthritis: Determining the OMERACT core domain setDiego Benavent, Loreto Carmona, Maria A Lopez-Olivo, et al.
Annals of the Rheumatic Diseases|December 5, 2023
2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseasesEmma Dures, Bayram Farisoğulları, Eduardo José Ferreira Santos, et al.
Annals of the Rheumatic Diseases|May 13, 2022
EULAR points to consider for therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal diseasesCharlotte Lm Krieckaert, Astrid van Tubergen, Johanna Elin Gehin, et al.
Seminars in Arthritis and Rheumatism|June 27, 2026
Development of a single‑item patient‑reported measure of treatment side‑effect burden in clinical trials of rheumatic and musculoskeletal diseases using stakeholder input and large language model refinementDorthe B Berthelsen, Ben Horgan, Lee Simon, et al.
Pageof 3